BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10675372)

  • 1. San Antonio Breast Cancer Symposium explores DCIS "battleground".
    Gottlieb N
    J Natl Cancer Inst; 2000 Feb; 92(4):295-7. PubMed ID: 10675372
    [No Abstract]   [Full Text] [Related]  

  • 2. Ductal carcinoma in situ, complexities and challenges.
    Leonard GD; Swain SM
    J Natl Cancer Inst; 2004 Jun; 96(12):906-20. PubMed ID: 15199110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ductal carcinoma in situ.
    Bleicher RJ
    Surg Clin North Am; 2013 Apr; 93(2):393-410. PubMed ID: 23464692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ductal Carcinoma In Situ: Treatment Update and Current Trends.
    Mitchell KB; Kuerer H
    Curr Oncol Rep; 2015 Nov; 17(11):48. PubMed ID: 26373411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast-conserving treatment for ductal carcinoma in situ: Impact of boost and tamoxifen on local recurrences.
    Cutuli B; Wiezzane N; Palumbo I; Barbieri P; Guenzi M; Huscher A; Borghesi S; Delva C; Iannone T; Vianello E; Rosetto ME; Aristei C
    Cancer Radiother; 2016 Jun; 20(4):292-8. PubMed ID: 27344537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggressive local treatment for screen-detected DCIS results in very low rates of recurrence.
    Jha MK; Avlonitis VS; Griffith CD; Lennard TW; Wilson RG; McLean LM; Dawes PD; Shrimankar J
    Eur J Surg Oncol; 2001 Aug; 27(5):454-8. PubMed ID: 11504515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The current clinical value of the DCIS Score.
    Wood WC; Alvarado M; Buchholz DJ; Hyams D; Hwang S; Manders J; Park C; Solin LJ; White J; Willey S
    Oncology (Williston Park); 2014 May; 28 Suppl 2():C2, 1-8, C3. PubMed ID: 25375000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ductal carcinoma in situ: a disease entity that merits more recognition.
    Dereere E; Papadimitriou K; Tjalma W; Altintas S
    Minerva Chir; 2015 Aug; 70(4):231-9. PubMed ID: 25916193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Assays in Ductal Carcinoma In Situ: Implications for Management Decisions.
    Gangi A; Topham A; Lee MC; Sun W; Laronga C
    South Med J; 2017 Oct; 110(10):649-653. PubMed ID: 28973706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ductal carcinoma in situ (DCIS) of the breast: diagnostic and therapeutic controversies.
    Silverstein MJ; Parker R; Grotting JC; Cote RJ; Russell CA
    J Am Coll Surg; 2001 Feb; 192(2):196-214. PubMed ID: 11220720
    [No Abstract]   [Full Text] [Related]  

  • 11. High nuclear grade and negative estrogen receptor are significant risk factors for recurrence in DCIS.
    Roka S; Rudas M; Taucher S; Dubsky P; Bachleitner-Hofmann T; Kandioler D; Gnant M; Jakesz R
    Eur J Surg Oncol; 2004 Apr; 30(3):243-7. PubMed ID: 15028303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary treatment of ductal carcinoma in situ of the breast.
    Mokbel K
    Med Sci Monit; 2005 Mar; 11(3):RA86-93. PubMed ID: 15735580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adjuvant therapy in breast cancer].
    Semiglazov VF
    Vopr Onkol; 2000; 46(1):18-27. PubMed ID: 10789218
    [No Abstract]   [Full Text] [Related]  

  • 14. Radiotherapy and tamoxifen after breast-conserving surgery for DCIS.
    Cunnick GH; Mokbel K
    Int J Fertil Womens Med; 2004; 49(5):237-8. PubMed ID: 15633483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate?
    Punglia RS; Schnitt SJ; Weeks JC
    J Natl Cancer Inst; 2013 Oct; 105(20):1527-33. PubMed ID: 24068769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of DCIS--results from clinical trials.
    Cuzick J
    Surg Oncol; 2003 Dec; 12(4):213-9. PubMed ID: 14998562
    [No Abstract]   [Full Text] [Related]  

  • 17. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
    Sakorafas GH; Tsiotou AG
    Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controversies in the Treatment of Ductal Carcinoma in Situ.
    Barrio AV; Van Zee KJ
    Annu Rev Med; 2017 Jan; 68():197-211. PubMed ID: 28099081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast conserving treatment for ductal carcinoma in situ in the elderly: can radiation therapy be avoided? Our experience.
    Falco G; Rocco N; Procaccini E; Sommella MG; Bordoni D; Cenini E; Castagnetti F; Sabatino V; Compagna R; Della Corte GA; Accurso A; Amato B; Ferrari G
    Int J Surg; 2014; 12 Suppl 2():S47-S49. PubMed ID: 25167849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intracystic papillary carcinoma of the breast: report of three cases].
    El mazghi A; Bouhafa T; Loukili K; El kacemi H; Lalya I; Kebdani T; Hassouni K
    Pan Afr Med J; 2014; 18():207. PubMed ID: 25419333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.